Everest Medicines to Announce Full-Year 2022 Financial Results on March 31, 2023
- Written by PR Newswire
SHANGHAI, March 15, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the full year ended December 31, 2022 and provide a business update on March 31, 2023....
Read more: Everest Medicines to Announce Full-Year 2022 Financial Results on March 31, 2023